NCT00576446View on ClinicalTrials.gov

Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Malignant Glioma
Interventions
BIOLOGICAL

Dendritic cell Vaccine

Patients will receive three vaccines every two weeks

Trial Locations (1)

90048

Cedars Sinai Medical center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT00576446 - Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients | Biotech Hunter | Biotech Hunter